# The Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2012 S.R. 2012/213 · made 22 May 2012 These Regulations add, in regulation 3, desoxypipradrol and other pipradrol‑related compounds to Schedule 1 to the Misuse of Drugs Regulations (Northern Ireland) 2002 (the “2002 Regulations”).Regulation 4 adds 7‑bromo‑5‑(2‑chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (commonly known as phenazepam), and regulation 5 adds any ester or ether of pipradrol, or any stereoisomeric form or salt or preparation or other product of such an ester or ether, to Schedule 3 to the 2002 Regulations. The schedule in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug. Made under: Misuse of Drugs Act 1971 (Section 7, Section 10, Section 22, Section 31, Section 38) PDFs: Printed copy https://openlegislation.uk/misuse-of-drugs-amendment-no2-regulations-northern-ireland-2012/pdf/nisr_20120213_en.pdf; Explanatory Memorandum https://openlegislation.uk/misuse-of-drugs-amendment-no2-regulations-northern-ireland-2012/pdf/nisrem_20120213_en.pdf ## Introductory text Dangerous Drugs Made 22nd May 2012 Coming into operation 13th June 2012 The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7.10,22 and 31 of the Misuse of Drugs Act 1971 as adapted by section 38 of that Act and now vested in it. In accordance with section 31(3) of that Act, it has consulted with the Advisory Council on the Misuse of Drugs. ## 1 Citation and commencement These Regulations may be cited as the Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2012 and shall come into operation on 13th June 2012. ## 2 Interpretation The Interpretation Act (Northern Ireland) 1954 shall apply to these Regulations as it applies to an Act of the Assembly ## 3 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002 The Misuse of Drugs Regulations (Northern Ireland) 2002 shall be amended as follows. ## 4 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002 In Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after paragraph 1(n), insert— “(o) Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say, (i) by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups; (ii) by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group; (iii) by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.”. ## 5 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002 In paragraph 1(a) of Schedule 3 (which specifies controlled drugs subject to the requirements of regulations 14, 15 (except Temazepam), 16, 18, 22, 23, 24, 26 and 27) after “Benzphetamine”, insert “7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one”. ## 6 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002 In Schedule 3 for paragraphs 2, 3 and 4, substitute— “2. Any stereoisomeric form of a substance specified in paragraph 1 or 3 not being phenylpropanolamine. 3. Any ester or ether of pipradrol. 4. Any salt of a substance specified in any of paragraphs 1 to 3. 5. Any preparation or other product containing a substance specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.”. ## Signature Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 22nd May 2012 (L.S.) Norman Morrow A senior officer of the Department of Health, Social Services and Public Safety ## Explanatory note (This note is not part of the Regulations) These Regulations add, in regulation 3, desoxypipradrol and other pipradrol‑related compounds to Schedule 1 to the Misuse of Drugs Regulations (Northern Ireland) 2002 (the “2002 Regulations”).Regulation 4 adds 7‑bromo‑5‑(2‑chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (commonly known as phenazepam), and regulation 5 adds any ester or ether of pipradrol, or any stereoisomeric form or salt or preparation or other product of such an ester or ether, to Schedule 3 to the 2002 Regulations. The schedule in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug. --- Source: https://www.legislation.gov.uk/nisr/2012/213 (the official version) Page: https://openlegislation.uk/misuse-of-drugs-amendment-no2-regulations-northern-ireland-2012 Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.